Home › Hidradenitis Suppurativa › New York › New York City
Hidradenitis Suppurativa clinical trials in New York City, NY
5 studies for Hidradenitis Suppurativa are looking for participants at sites in and around New York City (within about 30 miles). Open a study to see who can join and how to contact the study team.
Recruiting for a study here? Feature it at the top of this page — $99 for 30 days →
An Extension Study to Assess Safety and Efficacy of Remibrutinib in Participants With Moderate to Severe HS
RecruitingPhase 3
- Cameron Dermatology, New York
- Icahn School Of Med At Mount Sinai, New York
Safety and Efficacy of Soquelitinib in Adults With Hidradenitis Suppurativa
RecruitingPhase 1
- Clinical Site 5, New York
Study to Evaluate the Maximal Use of Ruxolitinib Cream in Adult and Adolescent Participants With Hidradenitis Suppurativa
RecruitingPhase 1
- Dr Bobby Buka, Md Greenwich Village, New York
- Equity Medical, Llc, New York
Rollover Study for Participants Previously Enrolled in Clinical Trials of Povorcitinib
RecruitingPhase 3
- Investigative Site US034, New York
- Investigative Site US081, New York
- Investigative Site US065, New York
- and 1 more
A Study of Zasocitinib in Adults With Hidradenitis Suppurativa
RecruitingPhase 2
- Mount Sinai Doctors, New York
About Hidradenitis Suppurativa
Hidradenitis suppurativa (HS), or acne inversa, is a chronic skin disease. It causes painful bumps in your armpits and groin. Learn about treatment.
More about Hidradenitis Suppurativa on MedlinePlus
Hidradenitis Suppurativa trials in other cities
- Boston, MA9 studies
- Tampa, FL7 studies
- Miami, FL6 studies
- Birmingham, AL5 studies
- Dallas, TX5 studies
- Phoenix, AZ5 studies
- New Orleans, LA4 studies
- Santa Clarita, CA4 studies
- Scottsdale, AZ4 studies
- Durham, NC4 studies
- Minneapolis, MN4 studies
- Philadelphia, PA4 studies
Other studies in New York City
- Breast Cancer136 studies
- Non-Small Cell Lung Cancer121 studies
- Cancer (all types)109 studies
- Prostate Cancer103 studies
- Metastatic Cancer93 studies
- Colorectal Cancer78 studies
- Ovarian Cancer69 studies
- Lung Cancer60 studies
- Multiple Myeloma60 studies
- Pancreatic Cancer60 studies
- Endometrial Cancer52 studies
- Acute Myeloid Leukemia51 studies
From ClinicalTrials.gov, data retrieved Oct 6, 2026. Each study sets its own eligibility; the study team decides who can join.